Recent news and posts
New experiment "Reinforced home support systems for the elderly people" under Article 51 of the Social Security Financing Act in France
On October 16, 2020, the Order of the Ministry of Solidarity and Health in relation to the new experiment on reinforced support for the elderly people (DRAD) was published in the Official Journal of the French Republic. The experiment offers a solution to elderly people with loss of autonomy who wish to stay at home, for whom "classic" support from home services is not more sufficient.
Article 51 of the Social Security Financing Act 2018 is the new scheme, which aims to improve cooperation between health actors and to decrease the partition of the health sector through innovative funding (for example, bundled payment) or innovation in the organization of healthcare. The projects eligible for funding via Article 51 has to improve access to healthcare, the efficiency of the system, relevance of prescription, and patient pathway. Thanks to this new approach, the innovative technologies can bypass one or more of the 63 regulations of social security financing laws, whether on the coordination of medical pathway, relevance, and quality of health, social or medico-social services, structuration of ambulatory cares and healthcare access. Experiments within this scheme are financed by the Innovation Fund for Health System (FISS, Fonds d'Innovation pour le Système de Santé), managed by the health insurance.
Since 2018, more than 60 experiments have been started under Article 51. In October, the new experiment on the home support of elderly people was added to the scheme. This alternative system offers integrated and reinforced coordination of the various professionals working with the elderly. It offers a base of additional services to the territory's existing offer, in a secure and suitable environment. The scope of the proposed experiment is national: it covers 19 departments and ten regions. The experiment is organized for three years, with a total cost of €21,381,820 (€1,004 per month and per patient).
The full details in French can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues are available for download free-of-charge.
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).